McGill Quality of Life Questionnaire (MQOL-16)

Description

The McGill Quality of Life Questionnaire (MQOL-16) is a brief version of the McGill quality-of-life instrument developed to assess the quality of life of individuals living with serious or advanced illnesses, including cancer and other terminal conditions.

The questionnaire focuses on the individual’s subjective experience and addresses several dimensions of quality of life, including physical, psychological, spiritual, and social aspects.

This multidimensional approach allows quality of life to be assessed beyond physical symptoms alone, providing a broader view of the patient’s overall well-being.

Purpose

The main purpose of the MQOL-16 is to provide a reliable and valid method for assessing quality of life in individuals with serious illness, taking into account the physical, emotional, spiritual, and social dimensions of their experience.

More specifically, the questionnaire aims to:

identify areas of life that may require improvement or additional support,

assess patients’ psychological and emotional condition,

and evaluate the quality of social relationships and the level of perceived support.

The questionnaire is described as particularly useful in palliative care and other healthcare settings in which quality of life is a primary goal of care.

Structure and Dimensions

According to the provided source, the MQOL-16 consists of 16 items assessing four principal areas:

Physical well-being: the patient’s physical condition and the level of pain or discomfort experienced.

Psychological well-being: emotional health, including levels of anxiety and depression.

Spiritual well-being: sense of meaning in life, acceptance of illness, and personal beliefs.

Social support: the quality of relationships with others and the social support received by the individual.

Scoring and Data Collection

The data obtained from the MQOL-16 are quantitative and, according to the source material, are collected through a Likert-type questionnaire.

The provided document does not specify the numerical response range or a detailed procedure for calculating the total score. Therefore, precise scoring should follow the official version of the instrument.

Responses may be used to describe the level of quality of life experienced by patients during different phases of illness.

Statistical Analysis

Several approaches to the analysis of MQOL-16 data are described in the source material.

Correlation analysis may be used to examine relationships between different quality-of-life dimensions and other psychological or clinical variables.

Factor analysis may be used to examine the questionnaire’s structure and identify the principal dimensions of quality of life being assessed.

Reliability analysis, including the calculation of Cronbach’s alpha, may be used to assess the internal consistency of questionnaire items.

Validity and Reliability

The psychometric evaluation of the MQOL-16, as described in the source document, may include reliability assessment, analysis of its factor structure, and validity testing.

Reliability analysis is used to evaluate the consistency and stability of responses.

Confirmatory factor analysis (CFA) may be used to determine whether the proposed structure of quality-of-life dimensions is supported by empirical data.

Validity testing is used to examine the instrument’s ability to effectively assess quality of life in patients with different levels of illness severity.

Applications

MQOL-16 data may be used to monitor patients’ quality of life during treatment or care, assess the effectiveness of interventions intended to improve quality of life, and identify patient needs in order to support better care and assistance.

Its multidimensional approach makes the questionnaire particularly useful in clinical and research settings where assessment of the patient’s overall experience is required rather than a focus solely on physical symptoms.

References

Cohen SR, Mount BM, Strobel MG, Bui F. The McGill Quality of Life Questionnaire: A measure of quality of life appropriate for people with advanced disease. Palliative Medicine. 1995;9(3):207–219.

Cohen SR, Mount BM. Living with cancer: “Good” days and “bad” days—What produces them? Can the McGill Quality of Life Questionnaire distinguish between them? Cancer. 2000;89(8):1854–1865.

Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. Journal of Palliative Care. 1991;7(2):6–9.